Soleno Therapeutics, Inc.SLNONASDAQ
Loading
PB Ratio: Discounted ValuationCompressed
Percentile Rank38
3Y CAGR-12.0%
5Y CAGR-16.2%
Year-over-Year Change
Price-to-book ratio
3Y CAGR
-12.0%/yr
vs +8.0%/yr prior
5Y CAGR
-16.2%/yr
Recent acceleration
Acceleration
-20.1pp
Decelerating
Percentile
P38
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 5.47 | -25.8% |
| 2024 | 7.37 | +74.8% |
| 2023 | 4.21 | -47.5% |
| 2022 | 8.03 | -12.6% |
| 2021 | 9.19 | -30.7% |
| 2020 | 13.27 | -60.5% |
| 2019 | 33.58 | +469.4% |
| 2018 | 5.90 | +93.7% |
| 2017 | 3.05 | -83.3% |
| 2016 | 18.28 | - |